7IZ Stock Overview
Develops dry powder preparations of biological pharmaceuticals. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ziccum AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.018 |
| 52 Week High | SEK 0.70 |
| 52 Week Low | SEK 0.001 |
| Beta | 1.34 |
| 1 Month Change | -71.38% |
| 3 Month Change | -91.25% |
| 1 Year Change | -96.93% |
| 3 Year Change | -98.26% |
| 5 Year Change | n/a |
| Change since IPO | -99.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7IZ | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -27.2% | -2.2% | -2.0% |
| 1Y | -96.9% | -15.6% | 6.9% |
Return vs Industry: 7IZ underperformed the German Pharmaceuticals industry which returned -15.6% over the past year.
Return vs Market: 7IZ underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| 7IZ volatility | |
|---|---|
| 7IZ Average Weekly Movement | 2,144.8% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7IZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7IZ's weekly volatility has increased from 1085% to 2145% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 10 | Ann Gidner | ziccum.com |
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Ziccum AB (publ) Fundamentals Summary
| 7IZ fundamental statistics | |
|---|---|
| Market cap | €531.25k |
| Earnings (TTM) | -€2.19m |
| Revenue (TTM) | €500.73k |
1.1x
P/S Ratio-0.2x
P/E RatioIs 7IZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7IZ income statement (TTM) | |
|---|---|
| Revenue | SEK 5.76m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 5.76m |
| Other Expenses | SEK 30.94m |
| Earnings | -SEK 25.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | -1.58 |
| Gross Margin | 100.00% |
| Net Profit Margin | -437.13% |
| Debt/Equity Ratio | 17.0% |
How did 7IZ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 18:51 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ziccum AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexander Vilval | Penser Access |